
1. baillieres best pract res clin gastroenterol. 2000 apr;14(2):255-64.

therapeutic options hcv--management infected individual.

foster gr(1), thomas hc.

author information: 
(1)the liver centre, imperial college school medicine st mary's hospital,
london, uk. g.foster@ic.ac.uk

patients chronic hepatitis c infection assessed liver biopsy
prior consideration anti-viral therapy. patients histologically mild
disease observed regular intervals assessed repeat liver 
biopsy interval 3-4 years. severe disease receive
early treatment interferon-alpha ribavirin. duration therapy is
determined genotype infecting virus-viral genotypes 2 3 require
only 6 months treatment genotypes treated 12 months.
approximately 35-40% treated patients respond therapy permanent
cessation viral replication improvement liver histology. new therapies 
including polyethylene glycol, pegylated, interferons combination regimes
involving amantadine currently evaluation hoped improved
regimes developed near future.

doi: 10.1053/bega.1999.0074 
pmid: 10890320  [indexed medline]

